Drugs / Butyphthalide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03394950 | May 2018 → May 2021 | ischemic stroke | Huisheng Chen | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Butyphthalide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03394950 ↗ |
| Known as | Butyl phthalide | “Butyl phthalide is type I chemical drugs.” NCT03394950 ↗ |
| Modality | Small molecule | “Butyl phthalide is type I chemical drugs.” NCT03394950 ↗ |
| Route | Intravenous | “Intravenous treatment with 25mg butyphthalide” NCT03394950 ↗ |